The Olympics only come round once every four years (excluding this year’s covid-driven 5-year gap). It’s a momentous occasion for athletes, but one little mistake can lay all the herculean effort and years of preparation in getting to the world’s biggest sporting event to waste. While not quite having the same dramatic flair, it takes a biotech company years to get a therapy in front of the regulators. By the same token, one misstep can send the company back to the drawing board. Which in a roundabout way, brings us to Iterum Therapeutics (ITRM).
https://www.tipranks.com/news/article/iterum-fda-rejects-uti-treatment-whats-next?utm_source=advfn.com&utm_medium=referral
Iterum Therapeutics (NASDAQ:ITRM)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Iterum Therapeutics Charts.
Iterum Therapeutics (NASDAQ:ITRM)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Iterum Therapeutics Charts.